PMID- 9118846 OWN - NLM STAT- MEDLINE DCOM- 19970423 LR - 20190813 IS - 0013-9580 (Print) IS - 0013-9580 (Linking) VI - 38 IP - 4 DP - 1997 Apr TI - Phenytoin-induced teratogenesis: a molecular basis for the observed developmental delay during neurulation. PG - 415-23 AB - PURPOSE: We wished to determine whether chronic phenytoin (PHT) exposure could impair neural development and if any morphological alterations could be linked to changes in gene expression. METHODS: Pregnant SWV mice were chronically administered PHT 40 mg/kg/day from gestational day (GD) 0:12 (day:h) until they were killed at various timepoints throughout neural tube closure (NTC). At each timepoint, embryos from both treated and control dams were collected and scored for their progression through NTC. The neural tubes were then isolated and subjected to in situ transcription (IST) and antisense RNA amplification procedures. Using these techniques, we examined the expression of 10 genes: N-cadherin (Ncad), collagen type IV (col-IV), bcl-2, c-jun, PAX-3, collular retinol binding protein-2 (CRBP-2), retinoic acid receptor alpha (RAR alpha), transforming growth factor(beta2) (TGF(beta2)), wee-1, and EMX-2. RESULTS: Chronic PHT exposure not only caused a delay in NTC whereby exposed embryos lagged behind the controls at each collection timepoint, but also significantly altered the expression of specific genes at distinct times during NTC. Early in NTC, PHT induced a significant reduction in the expression of N-cad, col-IV, and c-jun in exposed embryos as compared with controls. In contrast, during the midstages of NTC, the only significant molecular alterations observed in the PHT-exposed embryos was the continued decreased expression of col-IV and an increase in CRBP-2 expression. Finally, in the latter stages of NTC, PHT caused a significant reduction in the expression of bcl-2, RAR alpha, TGF(beta2), EMX-2, and PAX-3. CONCLUSIONS: These results show that although the effects of PHT are morphologically subtle, causing a delay in the development of the neural tube, this delay is accompanied by alterations in critical genes at crucial times of neural development that may account for the observed neurological deficits often associated with PHT exposure. FAU - Bennett, G D AU - Bennett GD AD - Department of Veterinary Anatomy and Public Health, College of Veterinary Medicine, Texas A&M University, College Station 77843-4458, USA. FAU - Lau, F AU - Lau F FAU - Calvin, J A AU - Calvin JA FAU - Finnell, R H AU - Finnell RH LA - eng GR - DE11303/DE/NIDCR NIH HHS/United States GR - ES07165/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Epilepsia JT - Epilepsia JID - 2983306R RN - 0 (Cadherins) RN - 0 (Cell Cycle Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (Homeodomain Proteins) RN - 0 (Nerve Tissue Proteins) RN - 0 (Nuclear Proteins) RN - 0 (PAX3 Transcription Factor) RN - 0 (Paired Box Transcription Factors) RN - 0 (Rbp2 protein, mouse) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinol-Binding Proteins) RN - 0 (Retinol-Binding Proteins, Cellular) RN - 0 (Transcription Factors) RN - 0 (empty spiracles homeobox proteins) RN - 138016-91-8 (Pax3 protein, mouse) RN - 6158TKW0C5 (Phenytoin) RN - 9007-34-5 (Collagen) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (Wee1 protein, mouse) SB - IM MH - Abnormalities, Drug-Induced/*etiology/genetics MH - Animals MH - Cadherins/biosynthesis/genetics MH - *Cell Cycle Proteins MH - Central Nervous System/drug effects/embryology MH - Collagen/biosynthesis/genetics MH - DNA-Binding Proteins/biosynthesis/genetics MH - Female MH - Gene Amplification MH - Gene Expression/drug effects MH - Genes, jun/drug effects/genetics MH - Homeodomain Proteins/biosynthesis/genetics MH - Mice MH - Mice, Inbred Strains MH - Nerve Tissue Proteins/biosynthesis/genetics MH - Neural Tube Defects/*chemically induced/genetics MH - *Nuclear Proteins MH - PAX3 Transcription Factor MH - Paired Box Transcription Factors MH - Phenytoin/*toxicity MH - Pregnancy MH - Protein-Tyrosine Kinases/biosynthesis/genetics MH - Receptors, Retinoic Acid/biosynthesis/genetics MH - Retinol-Binding Proteins/biosynthesis/genetics MH - Retinol-Binding Proteins, Cellular MH - *Transcription Factors EDAT- 1997/04/01 00:00 MHDA- 2000/05/16 09:00 CRDT- 1997/04/01 00:00 PHST- 1997/04/01 00:00 [pubmed] PHST- 2000/05/16 09:00 [medline] PHST- 1997/04/01 00:00 [entrez] AID - 10.1111/j.1528-1157.1997.tb01730.x [doi] PST - ppublish SO - Epilepsia. 1997 Apr;38(4):415-23. doi: 10.1111/j.1528-1157.1997.tb01730.x.